Skip to content
About
R&D
News/Media
Ethics
Support
About
R&D
News/Media
Ethics
Support
Company Overview
Milestones
Directions
Company Overview
Milestones
Directions
Pipeline
Publications
BiomeTreasure
Pipeline
Publications
BiomeTreasure
Press Releases
Media
Press Releases
Media
Ethical Charter
Anti-Corruption and Compliance Policy
Whistleblowing Center
Ethical Charter
Anti-Corruption and Compliance Policy
Whistleblowing Center
Announcements
Contact Us
Announcements
Contact Us
EN
KR
CN
EN
KR
CN
에이투젠, 혈당저하 프로바이오틱스 ‘HAC01’ NutraIngredients-Asia Awards 2024 수상
에이투젠, 미국 DDW서 마이크로바이옴 치료제 포스터 발표
에이투젠, 혈당케어 유산균 승승장구
에이투젠, ‘락토바실러스 플란타룸 균주 질염 예방 및 치료 효능’ 중국특허등록
에이투젠 ‘혈당엔유산균’, 현대홈쇼핑 및 홈엔쇼핑 연이어 런칭
(주)에이투젠 ‘혈당유산균 HAC01’, 2023 대한민국 특허기술상 수상
에이투젠, 마이크로바이옴 치료제 LABTHERA-001 임상1상 시험 완료
에이투젠, ‘락토바실러스 플란타룸 HAC01’ 미 자체 검증 GRAS 인증 취득
에이투젠, ‘L.plantarum HAC01’ 함유 건강기능식품 ‘혈당엔 유산균 HAC01’ 출시
에이투젠, ‘국내 최초’ 식후 혈당 상승 억제 프로바이오틱스 개별인정형 소재 획득
Previous
1
2
3
Next
About
Company Overview
Milestones
Directions
R&D
Pipeline
Overview
Therapeutics
Overview
Bacterial Vaginosis
Oncology
Allergic Diseases
Inflammatory Diseases
MASH
Functional Probiotics
Overview
Postprandial Blood Glucose Control
Body Fat Reduction
Muscle Function & Strength
Immune Health
Women’s Vaginal Health
Respiratory Health Support
Publications
BiomeTreasure
News/Media
Press Releases
Media
Ethics
Ethical Charter
Anti-Corruption and Compliance Policy
Whistleblowing Center
Support
Announcements
Contact Us
About
Company Overview
Milestones
Directions
R&D
Pipeline
Overview
Therapeutics
Overview
Bacterial Vaginosis
Oncology
Allergic Diseases
Inflammatory Diseases
MASH
Functional Probiotics
Overview
Postprandial Blood Glucose Control
Body Fat Reduction
Muscle Function & Strength
Immune Health
Women’s Vaginal Health
Respiratory Health Support
Publications
BiomeTreasure
News/Media
Press Releases
Media
Ethics
Ethical Charter
Anti-Corruption and Compliance Policy
Whistleblowing Center
Support
Announcements
Contact Us